Invasive lobular breast carcinoma (ILC) represents 5 to 15% of all invasive...
The levonorgestrel intra-uterine device (LNG-IUD) is a widely used...
Tucatinib is an oral HER2-targeted therapy that was approved by the FDA in...
One year of adjuvant trastuzumab with 12 cycles of weekly paclitaxel represents...
The 2020 ASCO-CAP guidelines recommended ER Low Positive as new reporting...
Dr. Vangoitsenhoven from KU Leuven evaluated how the adjuvant endocrine therapy...
Is the KI-67 level after neoadjuvant endocrine therapy associated with disease...